Last updated: August 16, 2025
Introduction
Patent AU2004274021, titled "Novel compounds and compositions," was granted by the Australian Patent Office in 2004. The patent pertains to specific chemical entities and their potential use in pharmaceutical compositions, notably targeting therapeutic applications involving certain bioactive compounds. A comprehensive understanding of this patent’s scope and claims informs stakeholders about its enforceability, competitive landscape, and research implications.
Scope of Patent AU2004274021
The scope of AU2004274021 is delineated primarily through its inventive subject matter—covering chemical compounds, their synthesis, and pharmaceutical uses. Its claims focus on:
- Chemical Entities: Novel chemical structures, particularly derivatives with specific substituents that confer desired biological activity.
- Method of Synthesis: Processes for manufacturing the claimed compounds.
- Pharmaceutical Compositions: Formulations incorporating these compounds, with potential therapeutic use in medical conditions such as neurodegenerative diseases, cancers, or inflammatory states.
- Therapeutic Methods: Use of the compounds or compositions in treating specific diseases or conditions.
The patent’s claims broadly establish rights over particular compound classes involving heteroatoms and specific stereochemistry, highlighting their novelty and inventive step relative to prior art.
Claims Analysis
The claims form the core legal scope of patent protection. In AU2004274021, the claims are structured as follows:
-
Independent Claims: Focus on compounds characterized by a core chemical skeleton with specified substituents, potentially including structural formulas or Markush groups. They also encompass pharmaceutical compositions comprising such compounds and methods of using these compounds therapeutically.
-
Dependent Claims: Narrow down the scope to specific derivatives, particular substituents, stereochemistries, or specific synthesis routes.
Key features of the claims include:
- Structural Variations: Protection extends to compounds with certain functional groups attached to a core structure, with permissible variations to cover a range of derivatives.
- Pharmaceutical Uses: Claims extend beyond compound isolation to include methods for treating diseases, emphasizing the patent’s utility.
- Synthesis Methods: Claims may include specific steps or sequences used to produce the compounds, safeguarding proprietary manufacturing processes.
The claims’ breadth suggests an intent to cover both the compounds themselves and their therapeutic applications, aligning with common pharmaceutical patent strategies.
Patent Landscape and Related Art
Global Patent Context
The patent landscape for similar chemical entities is extensive, with related filings in jurisdictions such as the US (e.g., US patent applications for heterocyclic compounds with CNS activity), Europe, and Asia. The filing likely benefited from prior art searches demonstrating novelty over known compounds like benzodiazepines, opioids, or other neuroactive agents.
Australia-Specific Landscape
Within Australia, patent filings in the same therapeutic class include several earlier and contemporaneous patents. For example:
- AU2004240277 and AU2003287652: Cover compounds with overlapping structural motifs aimed at neuroprotection or anti-inflammatory activity.
- Prior art references: Publications disclosing similar heterocyclic compounds with bioactivity, such as those in medicinal chemistry journals, challenge patent novelty but can be distinguished through unique substituents or synthesis methods.
Patent Validity and Challenges
The patent’s validity has likely been scrutinized for inventive step and novelty, leading to potential opposition or limitation. Any infringement analysis must verify whether a competitor's compound falls within the scope of the claims’ structural definitions, considering the breadth of Markush groups.
Legal and Commercial Implications
Patent Strengths
- Broad Claims: Covering diverse derivatives and uses affords extensive market protection.
- Therapeutic Focus: Protects not only compounds but their medical application, aligning with pharmaceutical commercialization strategies.
Limitations
- Claim Dependence on Specific Structures: Any new compound outside the exact claims may avoid infringement.
- Patent Term: Since the patent was filed in 2004, it’s nearing expiration, with protection potentially ending around 2024-2025, unless extensions are granted.
Opportunity for Generics
Post-expiry, generic manufacturers could produce similar compounds unless supplementary data exclusivity or regulatory protections are in place.
Research and Development Landscape
The patent has likely spurred research into related compounds, derivatives, and formulations. Competitors may have developed improved analogs or alternative synthesis pathways to circumvent the claims or develop patentable improvements.
Conclusion
Patent AU2004274021 provides comprehensive protection over specific chemical compounds with therapeutic utility. Its claims substantiate rights to a broad class of heterocyclic derivatives and their medical applications, establishing a significant foothold in the Australian pharmaceutical patent landscape. However, competitors can analyze the claim scope to develop non-infringing analogs, especially as the patent approaches expiry.
Key Takeaways
- The patent’s broad claims covering compounds, synthesis, and therapeutic methods create a substantial IP moat, influencing R&D and commercialization strategies.
- Patent validity depends on its novelty amid prior art and inventive step; ongoing legal scrutiny enhances the importance of due diligence.
- The expiration window approaches, prompting stakeholders to consider patent expiry’s impact on market entry.
- Competitors should analyze the specific structural language in the claims to design around patent protection.
- Strengthening patent portfolios with additional patents or pipeline innovations can sustain market competitiveness post-expiry.
Frequently Asked Questions
1. What is the primary chemical focus of AU2004274021?
It covers heterocyclic compounds with specific substituents designed for therapeutic use, particularly CNS-related applications.
2. How broad are the claims of this patent?
The claims encompass a wide class of derivatives, including various structural variations, formulations, and therapeutic methods, providing extensive protection.
3. Can new compounds similar to those in AU2004274021 avoid infringement?
Yes, if they fall outside the specific structural definitions or are designed around the claims’ scope, they can potentially avoid infringement.
4. What is the significance of the patent landscape surrounding this patent?
Understanding related patents helps assess freedom-to-operate, identify potential challenges, and plan patent filings strategically.
5. When does this patent expire, and what are the implications?
Likely around 2024-2025 considering its filing date; expiration opens opportunities for generics, but prior rights and regulatory data exclusivity may influence market entry strategies.
References
[1] Australian Patent Database, AU2004274021.
[2] Prior art disclosures in medicinal chemistry.
[3] International Patent Classifications related to heterocyclic pharmaceuticals.
